Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-02-14 4:10 pm Sale |
2024-12-31 | 13G | Celularity Inc. CELU |
BRISTOL MYERS SQUIBB CO BMY |
426,372 1.900% |
-768,955 (-64.33%) |
Filing History |
| 2025-01-28 4:30 pm Unchanged |
2025-01-24 | 13D | Celularity Inc. CELU |
Dragasac Ltd | 9,938,161 36.400% |
0 (Unchanged) |
Filing History |
| 2024-12-19 9:16 pm Purchase |
2024-07-15 | 13D | Celularity Inc. CELU |
Dragasac Ltd | 9,938,161 36.400% |
1,310,995 (+15.20%) |
Filing History |
| 2024-03-15 5:32 pm Purchase |
2024-03-13 | 13D | Celularity Inc. CELU |
Dragasac Ltd | 8,627,166 34.200% |
8,627,166 (New Position) |
Filing History |
| 2024-02-08 06:00 am Unchanged |
2023-12-31 | 13G | Celularity Inc. CELU |
UNITED THERAPEUTICS CORP UTHR |
796,885 4.110% |
0 (Unchanged) |
Filing History |
| 2024-01-17 5:15 pm Purchase |
2024-01-12 | 13D | Celularity Inc. CELU |
Dragasac Ltd | 8,327,168 33.600% |
4,326,373 (+108.14%) |
Filing History |
| 2023-10-05 5:22 pm Sale |
2023-09-29 | 13G | Celularity Inc. CELU |
Sorrento Therapeutics Inc. SRNEQ |
505,043 2.600% |
-1,537,170 (-75.27%) |
Filing History |
| 2023-06-22 4:36 pm Purchase |
2023-06-20 | 13D | Celularity Inc. CELU |
Dragasac Ltd | 4,000,795 21.000% |
341,536 (+9.33%) |
Filing History |
| 2023-02-13 5:13 pm Unchanged |
2022-12-31 | 13G | Celularity Inc. CELU |
STARR INTERNATIONAL CO INC | 1,528,139 10.540% |
0 (Unchanged) |
Filing History |
| 2023-02-13 5:12 pm Purchase |
2022-12-31 | 13G | Celularity Inc. CELU |
C V STARR & CO INC | 764,069 5.270% |
764,069 (New Position) |
Filing History |
| 2023-02-06 06:01 am Unchanged |
2022-12-31 | 13G | Celularity Inc. CELU |
UNITED THERAPEUTICS CORP UTHR |
796,885 5.500% |
0 (Unchanged) |
Filing History |
| 2023-02-03 07:28 am Purchase |
2021-07-16 | 13G | Celularity Inc. CELU |
UNITED THERAPEUTICS CORP UTHR |
796,885 6.510% |
796,885 (New Position) |
Filing History |
| 2022-02-04 12:07 pm Unchanged |
2021-12-31 | 13G | Celularity Inc. CELU |
Weiss Asset Management LP | 0 0.000% |
0 (Unchanged) |
Filing History |
| 2022-01-27 08:13 am Unchanged |
2021-12-31 | 13G | Celularity Inc. CELU |
HIGHBRIDGE CAPITAL MANAGEMENT LLC | 0 0.000% |
0 (Unchanged) |
Filing History |
| 2021-07-26 5:19 pm Purchase |
2021-07-16 | 13G | Celularity Inc. CELU |
Human Longevity Inc. | 701,257 5.700% |
701,257 (New Position) |
Filing History |
| 2021-07-26 5:16 pm Purchase |
2021-07-16 | 13D | Celularity Inc. CELU |
Hariri Robert J | 1,029,667 8.200% |
1,029,667 (New Position) |
Filing History |
| 2021-07-26 5:10 pm Purchase |
2021-07-16 | 13G | Celularity Inc. CELU |
BRISTOL MYERS SQUIBB CO BMY |
1,195,327 9.900% |
1,195,327 (New Position) |
Filing History |
| 2021-07-26 4:12 pm Purchase |
2021-07-16 | 13D | Celularity Inc. CELU |
Dragasac Ltd | 3,659,260 28.400% |
3,659,260 (New Position) |
Filing History |
| 2021-07-26 12:19 pm Purchase |
2021-07-16 | 13G | Celularity Inc. CELU |
STARR INTERNATIONAL CO INC | 1,528,139 11.800% |
1,528,139 (New Position) |
Filing History |
| 2021-07-23 06:02 am Purchase |
2021-07-16 | 13G | Celularity Inc. CELU |
Sorrento Therapeutics Inc. SRNEQ |
2,042,212 16.700% |
2,042,212 (New Position) |
Filing History |